nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylbutazone—SLC22A6—Stavudine—acquired immunodeficiency syndrome	0.123	0.129	CbGbCtD
Phenylbutazone—SLC22A11—Zidovudine—acquired immunodeficiency syndrome	0.121	0.127	CbGbCtD
Phenylbutazone—SLC22A6—Didanosine—acquired immunodeficiency syndrome	0.093	0.098	CbGbCtD
Phenylbutazone—SLC22A8—Zidovudine—acquired immunodeficiency syndrome	0.0702	0.0739	CbGbCtD
Phenylbutazone—SLC22A6—Zidovudine—acquired immunodeficiency syndrome	0.0489	0.0515	CbGbCtD
Phenylbutazone—SLC22A6—Lamivudine—acquired immunodeficiency syndrome	0.0378	0.0398	CbGbCtD
Phenylbutazone—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0363	0.0383	CbGbCtD
Phenylbutazone—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0341	0.036	CbGbCtD
Phenylbutazone—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0341	0.036	CbGbCtD
Phenylbutazone—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0309	0.0325	CbGbCtD
Phenylbutazone—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0309	0.0325	CbGbCtD
Phenylbutazone—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0267	0.0281	CbGbCtD
Phenylbutazone—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0259	0.0273	CbGbCtD
Phenylbutazone—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0234	0.0247	CbGbCtD
Phenylbutazone—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0234	0.0247	CbGbCtD
Phenylbutazone—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0224	0.0236	CbGbCtD
Phenylbutazone—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0211	0.0222	CbGbCtD
Phenylbutazone—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0199	0.0209	CbGbCtD
Phenylbutazone—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0199	0.0209	CbGbCtD
Phenylbutazone—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.018	0.0189	CbGbCtD
Phenylbutazone—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.018	0.0189	CbGbCtD
Phenylbutazone—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0155	0.0163	CbGbCtD
Phenylbutazone—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.015	0.0159	CbGbCtD
Phenylbutazone—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0136	0.0143	CbGbCtD
Phenylbutazone—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0136	0.0143	CbGbCtD
Phenylbutazone—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.013	0.0137	CbGbCtD
Phenylbutazone—PTGIS—endothelium—acquired immunodeficiency syndrome	0.0094	0.187	CbGeAlD
Phenylbutazone—PTGIS—lung—acquired immunodeficiency syndrome	0.00268	0.0533	CbGeAlD
Phenylbutazone—PTGIS—nervous system—acquired immunodeficiency syndrome	0.00248	0.0494	CbGeAlD
Phenylbutazone—PTGIS—central nervous system—acquired immunodeficiency syndrome	0.00239	0.0475	CbGeAlD
Phenylbutazone—PTGIS—brain—acquired immunodeficiency syndrome	0.0019	0.0377	CbGeAlD
Phenylbutazone—PTGIS—lymph node—acquired immunodeficiency syndrome	0.00183	0.0365	CbGeAlD
Phenylbutazone—SLC22A11—digestive system—acquired immunodeficiency syndrome	0.0018	0.0357	CbGeAlD
Phenylbutazone—PTGS1—endothelium—acquired immunodeficiency syndrome	0.00176	0.035	CbGeAlD
Phenylbutazone—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.00171	0.0341	CbGeAlD
Phenylbutazone—PTGS2—endothelium—acquired immunodeficiency syndrome	0.00168	0.0335	CbGeAlD
Phenylbutazone—PTGS1—blood plasma—acquired immunodeficiency syndrome	0.00156	0.0311	CbGeAlD
Phenylbutazone—PTGS2—blood plasma—acquired immunodeficiency syndrome	0.00149	0.0297	CbGeAlD
Phenylbutazone—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.00131	0.026	CbGeAlD
Phenylbutazone—SLC22A6—brain—acquired immunodeficiency syndrome	0.001	0.0199	CbGeAlD
Phenylbutazone—SLC22A8—blood—acquired immunodeficiency syndrome	0.000965	0.0192	CbGeAlD
Phenylbutazone—SLC22A8—nervous system—acquired immunodeficiency syndrome	0.000784	0.0156	CbGeAlD
Phenylbutazone—SLC22A8—central nervous system—acquired immunodeficiency syndrome	0.000754	0.015	CbGeAlD
Phenylbutazone—PTGS1—skin of body—acquired immunodeficiency syndrome	0.000752	0.015	CbGeAlD
Phenylbutazone—PTGS2—skin of body—acquired immunodeficiency syndrome	0.000718	0.0143	CbGeAlD
Phenylbutazone—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000659	0.0131	CbGeAlD
Phenylbutazone—CYP2C9—blood—acquired immunodeficiency syndrome	0.000627	0.0125	CbGeAlD
Phenylbutazone—PTGS1—digestive system—acquired immunodeficiency syndrome	0.000601	0.012	CbGeAlD
Phenylbutazone—SLC22A8—brain—acquired immunodeficiency syndrome	0.000599	0.0119	CbGeAlD
Phenylbutazone—PTGS2—lymphoid tissue—acquired immunodeficiency syndrome	0.000582	0.0116	CbGeAlD
Phenylbutazone—PTGS2—digestive system—acquired immunodeficiency syndrome	0.000575	0.0114	CbGeAlD
Phenylbutazone—PTGS1—blood—acquired immunodeficiency syndrome	0.000573	0.0114	CbGeAlD
Phenylbutazone—PTGS1—spinal cord—acquired immunodeficiency syndrome	0.000552	0.011	CbGeAlD
Phenylbutazone—PTGS2—blood—acquired immunodeficiency syndrome	0.000547	0.0109	CbGeAlD
Phenylbutazone—PTGS1—vagina—acquired immunodeficiency syndrome	0.000531	0.0106	CbGeAlD
Phenylbutazone—PTGS2—bone marrow—acquired immunodeficiency syndrome	0.00053	0.0105	CbGeAlD
Phenylbutazone—PTGS2—spinal cord—acquired immunodeficiency syndrome	0.000527	0.0105	CbGeAlD
Phenylbutazone—PTGS2—vagina—acquired immunodeficiency syndrome	0.000507	0.0101	CbGeAlD
Phenylbutazone—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000502	0.00999	CbGeAlD
Phenylbutazone—PTGS1—lung—acquired immunodeficiency syndrome	0.000502	0.00999	CbGeAlD
Phenylbutazone—PTGS2—lung—acquired immunodeficiency syndrome	0.00048	0.00955	CbGeAlD
Phenylbutazone—CYP3A4—blood—acquired immunodeficiency syndrome	0.000478	0.00952	CbGeAlD
Phenylbutazone—PTGS1—nervous system—acquired immunodeficiency syndrome	0.000465	0.00925	CbGeAlD
Phenylbutazone—PTGS1—central nervous system—acquired immunodeficiency syndrome	0.000448	0.00891	CbGeAlD
Phenylbutazone—PTGS2—nervous system—acquired immunodeficiency syndrome	0.000444	0.00884	CbGeAlD
Phenylbutazone—PTGS2—central nervous system—acquired immunodeficiency syndrome	0.000428	0.00851	CbGeAlD
Phenylbutazone—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000388	0.00773	CbGeAlD
Phenylbutazone—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000374	0.00744	CbGeAlD
Phenylbutazone—PTGS1—brain—acquired immunodeficiency syndrome	0.000355	0.00707	CbGeAlD
Phenylbutazone—PTGS1—lymph node—acquired immunodeficiency syndrome	0.000343	0.00683	CbGeAlD
Phenylbutazone—PTGS2—brain—acquired immunodeficiency syndrome	0.00034	0.00676	CbGeAlD
Phenylbutazone—Fosphenytoin—ALB—acquired immunodeficiency syndrome	0.000332	0.47	CrCbGaD
Phenylbutazone—PTGS2—lymph node—acquired immunodeficiency syndrome	0.000328	0.00653	CbGeAlD
Phenylbutazone—Phenprocoumon—ALB—acquired immunodeficiency syndrome	0.000228	0.322	CrCbGaD
Phenylbutazone—Phenytoin—ALB—acquired immunodeficiency syndrome	0.000147	0.208	CrCbGaD
